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We implemented a hospital-based prevention with positives (PwP) intervention among peo-
ple living with HIV (PLHIV) that included HIV transmission risk screening, short HIV preven-
tion messages, family planning, HIV disclosure counseling, and partner HIV testing at five
hospitals in Thailand. We assessed changes in sexual risk behaviors among PLHIV who
received the PwP services at the hospitals.
Methods
From January 2008-March 2009, we systematically selected a subset of PLHIV receiving
care at the five hospitals to offer participation in the PwP intervention. We collected demo-
graphic, risk behavior, and laboratory data using a standardized questionnaire. We ana-
lyzed data from PLHIV who completed at least four visits, using generalized estimating
equations to identify baseline participant characteristics that were associated with adopting
sexual practices less likely to be associated with HIV transmission during follow-up.
Results
A total of 830 PLHIV were interviewed and 756 (91.1%) completed four visits. The median
age of these 756 participants was 37 years, 400 (52.9%) were women, and 475 (62.8%) had
a steady partner. At baseline, 353 (74.3%) of the steady partners had been tested for HIV
and 132 (37.4%) had tested negative. Among the 756 PLHIV, 427 (56.5%) reported having
sex in the 3 months before enrollment and 413 (54.6%) in the 3 months before the fourth
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visit. The proportion reporting having vaginal or anal sex without a condom decreased from
20.8% at baseline to 5.1% at the fourth visit (p<0.001). Factors associated (p<0.05) with
abstinence or 100% condom use at follow-up visits included: completing two visits, being
diagnosed with HIV for longer than 3 months, and receiving HIV prevention messages from
a doctor (versus a nurse or counselor).
Conclusion
Safe sex behaviors increased among PLHIV receiving PwP services, suggesting that
expansion of hospital-based PwP services may reduce the number of new HIV infections in
Thailand.
Introduction
In 2014, the Government of Thailand issued new HIV treatment guidelines [1] recommending
antiretroviral treatment (ART) for people living with HIV (PLHIV) regardless of CD4 count.
ART was recommended for all PLHIV because of new evidence showing that early initiation
of ART can improve the health of PLHIV, suppress HIV viral load, and reduce the risk of
transmitting HIV to others [2–4]. The early use of ART provides PLHIV another tool to
reduce the risk that they will transmit HIV to their sexual and needle-sharing partners. How-
ever, although the risk of HIV transmission with consistent ART use is low, it is not zero [5]
and data from the HIV treatment and care cascades in many countries [6, 7] indicate that a
substantial number of PLHIV who need ART are not receiving ART and that less than 50% of
PLHIV engaged in care achieve undetectable HIV viral loads. Thus, behavioral and other risk-
reduction interventions such as Prevention with Positives (PwP) remain important tools to pre-
vent HIV transmission.
PwP interventions encourage PLHIV to take steps to maintain and improve their health, to
prevent transmission of HIV and other sexually transmitted infections (STIs) to sexual and
needle-sharing partners, and to prevent unintended pregnancies to limit HIV transmission
from HIV-infected mothers to their new-born infants [8] while allowing full and satisfying
emotional and sexual relationships [8–12]. A recent meta-analysis of 21 randomized clinical
trials showed that PwP interventions, including either group or individual interventions, sig-
nificantly reduced the frequency of condomless anal and vaginal intercourse [13].
Division of Global HIV and TB (DGHT), U.S. Centers for Disease Control and Prevention
(CDC), Thailand office worked with Thailand MOPH to develop a PwP model for health care
settings that included a package of HIV prevention tools and services for PLHIV and their part-
ners (Fig 1). The model was piloted in seven settings in Thailand during 2008–2009 [8, 14]. We
previously described the PwP model and use of dual contraceptive methods by PLHIV who par-
ticipated in the PwP program [8]. Here we briefly describe the PwP model, assess the risk behav-
iors of PLHIV who received PwP services and completed four clinical visits, and examine factors
associated with a change to sexual behaviors less likely to be associated with HIV transmission.
Materials and methods
The Prevention with Positives (PwP) model
Staff from the Thailand MOPH, Bureau of AIDS, Tuberculosis, and STIs and DGHT worked
with health care providers from seven hospitals (i.e., three government (MOPH) hospitals, two
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Bangkok Metropolitan Administration (BMA) hospitals, one MOPH STI clinic, and one uni-
versity hospital) to develop PwP tools and determine what services to include in the PwP
model using published PwP models to guide discussions [8, 15–17]. The goals of the PwP
intervention were to prevent HIV transmission by screening PLHIV for behavior risks, pro-
vide targeted risk reduction messages, improve PLHIV ART adherence, screen PLHIV for and
Fig 1. Flowchart of the Prevention with Positives (PwP) program for people living with HIV (PLHIV) in Thai hospitals. *Short
prevention messages are provided to all PLHIV at routine clinical visits, covering all strategies in the initial visit and specific patient-
centered strategies at follow-up visits. **High-risk/complicated case defined as people who inject drugs who report sharing needles,
people who report sex without a condom, and people who have a history of STIs.
doi:10.1371/journal.pone.0170558.g001
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treat STIs, promote HIV status disclosure to partners, and encourage partner HIV testing and
family planning [8, 18].
The PwP tools and services in the preliminary PwP package included a self-administered
risk assessment questionnaire, educational posters, scripts for brief provider-delivered preven-
tion messages, an educational flipchart, a participant information pamphlet, and guidance for
client-centered counseling [14]. These materials were field tested at the seven pilot sites and
the package was revised and finalized based on feedback from field site staff. The risk assess-
ment questionnaire included questions about participant’s current ART regimen and dosing
frequency, ART adherence (i.e., the number of doses missed in the previous 3 days and the
number of doses missed in the previous month), sexual activity in the previous 3 months, con-
dom use during the most recent sexual exposure, alcohol consumption during the previous 3
months, STI symptoms, partner HIV disclosure status, HIV testing history, and use of family
planning tools. At each clinical visit, PLHIV were given the risk assessment questionnaire to
complete. Trained health care staff and PLHIV volunteers were available to assist participants
with the questionnaire as needed. Health care providers in the seven sites were trained to
deliver the PwP package and to provide the brief prevention messages to all PLHIV attending
the clinic based on risks reported in the risk assessment questionnaire. PLHIV who injected
drugs, reported having sex without a condom, were sex workers, and had a history of STIs
were referred for additional, more specific, participant-centered counseling (e.g., risk reduc-
tion counseling, partner HIV disclosure counseling, ART adherence counseling). When
indicated, participants were referred for other services (e.g., antenatal care or peer support
groups). The study protocol and consent forms were approved by the Ethical Review Commit-
tees of the Thailand MOPH, the BMA, Siriraj Hospital, and the U.S. CDC Institutional Review
Board. PLHIV who signed the consent form were enrolled in the PwP program.
Data collection and analysis
Non-pregnant PLHIV 18 years old and older who received services at the seven hospitals from
January 2008 to March 2009 were eligible to enroll. At each site, every sixth eligible person was
provided information about the PwP program and the assessment by the trained counselors.
PLHIV who signed the consent form were enrolled in the assessment. Participants completed
a baseline questionnaire and were followed every three months until they completed three fol-
low-up visits for a total of four visits. If an individual did not agree to enroll, the next eligible
person was provided information about the assessment and invited to enroll.
Among the seven sites, one site, an out-patient STI clinic providing diagnostic and treat-
ment services for STIs and HIV testing, did not provide follow-up data and one hospital was
unable to provide sufficient data for analysis. These two sites were excluded from this analysis.
The five hospitals included in the analysis were Rajavithi Hospital, Siriraj Hospital, Taksin
Hospital, Vajira Hospital, and Wiang Pa Pao Hospital (Table 1).
Data were entered into a Microsoft Access database and analyzed using STATA (version
11.0, Stata Corp., Texas, United States). In Thailand in 2008–2009, people receiving ART were
followed at hospitals or clinics every two to three months. Only data from participants who
completed four or more scheduled visits during a 12-month period were included in the analy-
sis. We used McNemar’s Chi-square tests to test for differences in proportions (bivariable anal-
ysis) of participants reporting risk behaviors at the baseline and the fourth visit (the month 12
visit). We used generalized estimating equations (GEE) to identify baseline participant charac-
teristics that were associated with adopting sexual practices less likely to be associated with
HIV transmission during follow-up (i.e., changing from reporting sex without a condom at
baseline to reporting abstinence or 100% condom use at the first follow-up visit). This allowed
Prevention with positives among people living with HIV, Thailand
PLOS ONE | DOI:10.1371/journal.pone.0170558 February 3, 2017 4 / 14
us to account for correlations within subjects measured longitudinally. Variables with a p-
value0.10 in bivariable analysis were included in a multivariable analysis.
Results
Participant recruitment and characteristics
A total of 830 PLHIV agreed to enroll and completed the baseline PwP risk assessment ques-
tionnaire at the five hospitals. Of these, 756 (91.1%) completed four visits and were included in
the analysis. The median age of the 756 participants was 37 years, 400 (52.9%) were female,
and 438 (57.9%) had completed high school or a higher level of education. The median time
since HIV diagnosis was 5 years. Participants had a median CD4 count of 356 cells/mm3 at
study enrollment and 632 (83.6%) were taking ART (Table 2).
At baseline, 427 (56.5%) participants reported having sex during the previous 3 months
including 39 (9.1%) who reported sex with a casual partner and 20 (4.7%) who reported sex
with a sex worker. Among participants who had sex, 338 (79.2%) reported using condoms
100% of the time (data not shown) and 89 (20.8%) reported having vaginal or anal sex without
a condom during the previous 3 months (Table 3). Among the 475 PLHIV with a steady part-
ner, 406 (85.5%) had disclosed their HIV status to their partners, and 353 (74.3%) of all the
partners had been tested for HIV; 132 (37.4%) partners tested HIV negative (i.e., HIV serodis-
cordant). ART adherence data were available on 625 participants; 616 (98.6%) reported95%
adherence during the past month. Among the 427 participants who reported having sex during
the previous 3 months, 403 (94.4%) reported using contraception; 355 (88.1%) used condoms
and 114 (28.3%) had been sterilized. A total of 150 (19.8%) participants reported no sexual
intercourse (abstinence) during the 3 months before baseline and all follow-up visits through
the fourth visit.
PwP interventions and HIV risk behaviors
Among participants who had sexual intercourse, the proportion of participants reporting sex
without a condom decreased from 20.8% (89 of 427) at baseline to 5.1% (21 of 413) at month
12 (p<0.001) and the proportion reporting sex without a condom with a casual partner
decreased from 12.8% (5 of 39) at baseline to 5.9% (1 of 17) at month 12 (p = 0.44) (Table 3).
Of the 356 male participants, 23 (6.5%) reported having sex with a man during the 3 months
before enrollment and four (17.4%) did not use a condom; 20 (5.6%) reported sex with a man
during the 3 months before the month 12 visit and two (10%) did not use a condom (P = 0.67).
Table 1. Characteristics of hospitals participating in prevention with positives intervention assessment, Thailand, 2008–2009.
Site Hospital description Managing Institution Approximate number of PLHIV receiving care
during the study
Location
Rajavithi Hospital Tertiary care hospital (1,182 in-patient
beds)
Thailand Ministry of Public
Health
1,000 Bangkok
Siriraj Hospital Tertiary care, university hospital (2,221
in-patient beds)
Mahidol University 1,200 Bangkok
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Only nine (1.2%) participants reported that they had sex in exchange for money or gifts, and
three (0.4%) reported injecting drugs at baseline. About half of the participants who reported
having sex for money and who reported injecting drugs at baseline had sex without using a
condom. None of the three participants who reported having sex in exchange for money at
month 12 reported they had sex without a condom, but the change was not statistically
significant.
Among the 475 participants with a steady partner, 406 (85.5%) reported that they had dis-
closed their HIV status to their partners at baseline; at the month 12 visit, 414 (89.6%) of the
462 participants with steady partners had disclosed their HIV status (p = 0.01) and partner
HIV testing increased from 74.3% (353 of 475 partners) at baseline to 83.1% (384 of 462 part-
ners) at the month 12 visit (p<0.001). Fewer participants reported they were planning a future
pregnancy at the month 12 visit than at baseline (p<0.001). The proportion of participants
Table 2. Baseline characteristics of people living with HIV enrolled in the prevention with positives
intervention assessment at five hospitals, Thailand, 2008–2009.
Characteristics (N = 756) n (%)
Site where participants enrolled
Siriraj Hospital 235 (31.1)
Vajira Hospital 199 (26.3)
Taksin Hospital 161 (21.3)
Wiang Pa Pao Hospital 84 (11.1)




Median age in years (range) 37 (19–72)
Marital status
Single 156 (20.6)
Married or living with live-in partner 437 (57.8)
Divorced or separated 163 (21.6)
Education
primary school 317 (41.9)
Attended or completed secondary school 328 (43.4)
Bachelor degree or higher 110 (14.6)
Occupation
Irregularly employed 272 (36.0)
Unemployed 131 (17.3)
Employee 117 (15.5)
Civil servant 69 (9.1)
Others 167 (22.1)
Self-reported source of HIV infection
Heterosexual sex 625 (82.7)
Blood transfusion 18 (2.4)
Injecting drugs 34 (4.5)
Homosexual sex 47 (6.2)
Unknown/other 30 (4.0)
Median time since HIV diagnosis in years (range) 5 (0.3–21)
Currently on antiretroviral therapy 632 (83.6)
Median CD4 (cells/mm3) (range) 356 (1–1793)
doi:10.1371/journal.pone.0170558.t002
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Table 3. Risk behaviors reported by people living with HIV participating in the prevention with positives intervention assessment, Thailand, 2008–
2009.
Strategies/Behaviors (N = 756) Visit P value
Baseline (first visit) Month 12 (fourth visit)
n (%) n (%)
Risk behaviors during the previous 3 months
Had vaginal or anal sexual intercourse 427/756 (56.5) 413/756 (54.6) 0.27
Had vaginal or anal sex without a condom 89/427 (20.8) 21/413 (5.1) <0.001*
Had sex with a casual partner 39/756 (5.2) 17/756 (2.2) <0.001
Had sex without a condom with a casual partner 5/39 (12.8) 1/17 (5.9) 0.44*
Had sex with a sex worker 20/756 (2.6) 8/756 (1.1) 0.01
Had sex without a condom with a sex worker 6/20 (30.0) 0/8 (0.0) N/A
Used illicit drugs# 11/756 (1.5) 18/756 (2.4) 0.21
Consumedone alcohol drink 98/756 (13.0) 49/756 (6.5) <0.001
Men who had sex with men 23/356 (6.5) 20/356 (5.6) 0.53
Had sex without a condom 4/23 (17.4) 2/20 (10.0) 0.67**
Was paid or received gifts for sex 9/756 (1.2) 3/756 (0.4) 0.11
Had sex without a condom 5/9 (55.6) 0/3 (0.0) 0.20**
Injected drugs 3/756 (0.4) 0/756 (0.0) 0.25
Had sex without a condom 1/2¶ (50.0) 0/0 (0.0) N/A
Diagnosis of sexually transmitted infection (STI) during the previous 3 months
Diagnosed with an STI@ 4/756 (0.5) 2/756 (0.3) 0.69
Had STI symptom(s)@@ 43/756 (5.7) 13/756 (1.7) <0.001
HIV disclosure to partner
Had a steady partner^ 475/756 (62.8) 462/756 (61.1) 0.17
HIV status disclosed to steady partner 406/475 (85.5) 414/462 (89.6) 0.01
Steady partner tested for HIV 353/475 (74.3) 384/462 (83.1) <0.001
Steady partner HIV status
HIV positive 217/353 (61.5) 231/384 (60.1)
HIV negative 132/353 (37.4) 150/384 (39.0)
Unknown 4/353 (1.1) 2/384 (0.5)
ART adherence$ and HIV viral load
95% ART adherence 616/625 (98.6) 621/625 (99.4) 0.27
HIV viral load50 copies/mL 229/349 (65.6) 487/553 (88.1) <0.001
Median HIV viral load in copies/ml (range) 50 (0, 484000) 47 (40, 750000)
Pregnancy plans and contraceptive use
Planning a future pregnancy 26/756 (3.4) 4/756 (0.5) <0.001
Contraceptives used (sexually active participants) 403/427 (94.4) 398/413 (96.4) 0.10
Hormonal pills 31/403 (7.7) 23/398 (5.8)
Hormonal injection 10/403 (2.5) 7/398 (1.8)
Hormonal implantation 21/403 (5.2) 31/398 (7.8)
Condoms 355/403 (88.1) 372/398 (93.5)
Condoms with others (specify) 132/355 (37.2) 157/372 (42.2)
Condoms and oral pills 25/132 (18.9) 22/157 (14.0)
Condoms and hormonal injection 5/132 (3.8) 7/157 (3.2)
Condoms and hormonal implantation 15/132 (11.4) 29/157 (18.5)
Condoms and sterilization 87/132 (65.9) 99/157 (63.1)
(Continued )
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with an HIV viral load50 copies/mL increase from 229 (65.6%) of 349 participants at base-
line to 487 (88.1%) of 553 participants at the month 12 visit (p<0.001).
Factors associated with abstinence and condom use
The number of participants who reported that they had abstained from sex or used condoms
100% of the time during the previous 3 months (i.e., participants who did not report having
vaginal or anal sex without a condom in Table 3) increased from 667 (88.2%) at baseline to 735
(97.2%) at the month 12 visit (adjusted odds ratio [aOR] 1.9, 95% confidence interval [CI] 1.6
to 2.5, p<0.001, per visit) (data not shown). Factors associated with an increase in sexual prac-
tices less likely to be associated with HIV transmission (i.e., abstaining from sex or 100% con-
dom use) in multivariable analysis included: having sought care at Vajira (p<0.001), Taksin
(p<0.001) or Wiang Pa Pao (p = 0.02) Hospitals compared with Siriraj Hospital; having been
diagnosed with HIV for 3 or more months, compared with less than 3 months (p<0.001); not
receiving condoms at the first visit, compared with having received condoms (p = 0.007); and
having received risk reduction messages from a doctor, compared with having received risk
reduction messages from a health care provider that was not a doctor (e.g., a nurse or counsel-
lor) (p = 0.002) (Table 4). Based on the results of the GEE analysis, participants in these groups
were about 50% less likely to engage in sexual behaviors associated with HIV transmission dur-
ing follow-up than reported at baseline.
Discussion
We developed and implemented a PwP program in hospitals in Thailand. After participating
in the PwP program for one year, PLHIV were more likely to have disclosed their HIV status
to their partner, to have used condoms when having vaginal or anal sex, and to have an HIV
viral load result50 copies/mL than they were at baseline. This is consistent with previous
studies [12, 19–21] that have shown that PwP interventions delivered to groups or individuals
can effectively reduce risk behaviors associated with HIV transmission.
PLHIV who had been diagnosed with HIV for 3 or more months were more likely to report
abstinence or 100% condom use than PLHIV who had been diagnosed for less than 3 months
Table 3. (Continued)
Strategies/Behaviors (N = 756) Visit P value
Baseline (first visit) Month 12 (fourth visit)
n (%) n (%)
Sterilization 114/403 (28.3) 116/398 (29.1)
*Z test for proportion
** Fisher exact test was used when the observed value was less than 5 in each cell
# Illicit drugs included injecting drugs (e.g., heroin) and hallucinogens.
¶ Two people who injected drugs had sex during the last 3 months
@ STI includes clinician-diagnosed genital ulcer disease; a positive test result for gonorrhea, chlamydia, or trichomonas; or a positive syphilis result (i.e.,
RPR titer >1:8 and a reactive TPHA test).
@@ STI symptoms defined as having: dysuria, pain in genital area, swollen testis, vaginal discharge, pain in lower abdomen, genital ulcer, vesicles, urethral
discharge, anal discharge, or wart.
^A “steady partner” was defined as a person that the participant had known for more than two months, regularly had sex with, and with whom the participant
felt a psychological connection.
$ART adherence was assessed each visit using PLHIV self-report of antiretroviral use during the previous 3 days and the previous month and was available
on 625 participants.
doi:10.1371/journal.pone.0170558.t003
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and PLHIV were more likely to report abstinence or 100% condom use at follow-up visits than
at baseline. Other PwP assessments have also shown that participants’ sexual risk behaviors
decrease over time [22] suggesting that a longer participant-health care provider relationship
and greater exposure to PwP messages may be associated with an increased uptake of PwP
activities [10]. PLHIV who received risk reduction messages from a doctor were more likely to
report abstinence or 100% condom use during follow-up than participants who received these
messages from other staff. This is consistent with other studies that have shown that doctors
can have an important impact on patient behaviors [23].
Our study also found that PLHIV who received care at Vajira and Taksin Hospitals, man-
aged by the city government of Bangkok (i.e., BMA), were more likely to report abstinence
or 100% condom use during follow-up than PLHIV who received care at the University Hos-
pitals in Bangkok. HIV clinic staff at the BMA hospitals provide PwP services as part of
Table 4. Results of generalized estimating equation analysis of baseline factors associated with change from condomless sex to abstinence or
100% condom use at follow-up visits among PLHIV participating in prevention with positives intervention assessment, Thailand, 2008–2009.
Variables Bivariate analysis Multivariate analysis
OR*(95% CI) p-value aOR*(95% CI) p-value
Clinical visit (n = 756)
Fourth 4.7 (3.0–7.3) <0.001 4.8 (3.0–7.5) <0.001
Third 6.1 (3.7–10.3) <0.001 6.1 (3.6–10.5) <0.001
Second 2.4 (1.7–3.2) <0.001 2.4 (1.7–3.3) <0.001
First 1.0 1.0
Hospital (n = 756)
BMA Vajira Hospital 4.1 (2.2–7.8) <0.001 3.5 (1.8–6.7) <0.001
BMA Taksin Hospital 3.1 (1.8–5.5) <0.001 2.8 (1.6–4.9) <0.001
Wiang Pa Pao Hospital 2.4 (1.2–5.1) 0.20 2.5 (1.4–5.4) 0.02
Rajavithi Hospital 0.9 (0.5–1.5) 0.61 1.0 (0.5–1.8) 0.98
Siriraj Hospital 1.0 1.0
Received condoms at first visit (n = 756)
Yes 0.5 (0.3–0.7) <0.001 0.5 (0.3–0.8) 0.007
No 1.0 1.0
Received short risk reduction messages from doctor at baseline (n = 756)
Yes 1.7 (1.1–2.4) 0.002 1.9 (1.2–2.8) 0.002
No 1.0 1.0
Disclosure to steady partner prior to first visit (n = 756)
Yes (or no steady partner) 1.5 (1.0–2.3) 0.03 NS
No 1.0 1.0
Steady partner tested for HIV prior to first visit (n = 756)
Yes (or no steady partner) 1.4 (0.9–2.0) 0.10 NS
No/don’t know 1.0 1.0
At first visit, time since HIV diagnosis (n = 746)
<3 months 0.4 (0.2–0.6) <0.001 0.4 (0.2–0.6) <0.001
3 months 1.0 1.0
At first visit, alcohol or drug use during previous 3 months (n = 756)
Yes 0.6 (0.4–0.9) 0.02 NS
No 1.0 1.0
OR odds ratio, aOR adjusted odds ratio, CI confidence interval
* Adjusted for visit number
doi:10.1371/journal.pone.0170558.t004
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routine clinic activities and have established long-term relationships with clinic patients
and other hospital staff. A case manager was hired to provide PwP services at Siriraj Hospital
for this project. The Siriraj Hospital PwP staff may not have had sufficient time to develop
strong relationships with patients to support behavior change. In addition, Siriraj Hospital
is a national referral center and likely cares for a higher proportion of PLHIV with a history
of treatment failure, adherence challenges, and higher HIV associated risk behavior than
PLHIV at other hospitals.
PLHIV who did not receive condoms at their first visit were more likely to report absti-
nence or 100% condom use during follow-up than PLHIV who received condoms. This find-
ing is counter-intuitive. However, condoms were not randomly distributed during the study;
health care providers gave condoms to PLHIV who they perceived were sexually active or at
risk of HIV or STI transmission and to PLHIV requesting condoms (Fig 1). This may have
resulted in a selection bias with PLHIV who received condoms representing a population at a
higher risk of having sexual intercourse without a condom than those who did not receive con-
doms. It may also indicate that those who engaged in risk behaviors did not receive a sufficient
number of condoms or that distributing condoms alone is not an adequate prevention strategy
for this group. Further investigation to understand why these patients continued to engage in
sexual activities associated with HIV infection is necessary.
During the study, self-reported ART adherence was high (i.e., 99%) and the proportion of
PLHIV with HIV viral load results50 copies/mL at the fourth visit was higher than baseline.
Nonetheless, although PLHIV in this study reported high levels of ART adherence, 12% had a
detectable viral load at the month 12 visit, suggesting that self-reported adherence may not
reflect true adherence or that HIV drug resistance may exist among some participants [24].
We found that almost 40% of participants were in HIV serodiscordant relationships which is
in line with other reports [25]. The number of PLHIV in serodiscordant relationships and the
frequency that virus is detectable among PLHIV receiving ART highlights the importance of
PwP services and routine viral load monitoring to identify PLHIV with adherence challenges
or ART resistance who may need additional adherence support or a change in their ART
regimen. Antiretroviral pre-exposure prophylaxis (PrEP) can reduce the risk of HIV transmis-
sion to HIV-uninfected partners in serodiscordant relationships [26] and the 2014 Thailand
National HIV Treatment and Care Guidelines recommend that providers consider PrEP for
HIV-uninfected partners who do not use condoms consistently as part of a comprehensive
HIV prevention strategy [1].
In Thailand, patients are usually assessed for STIs only when they report symptoms to their
care providers [27]; however, in the PwP program, participants were asked about STI symp-
toms at each visit and participants with symptoms were treated. We found a decrease in STI
symptoms and diagnoses at the month 12 visit compared to baseline, consistent with studies
[28] showing that implementing interventions to diagnose and treat STIs among PLHIV can
reduce STI incidence.
Several studies have shown that PwP interventions can increase the proportion of PLHIV
who disclose their HIV status to their partners [21, 25]. In this study, we found that a relatively
high proportion of PLHIV (i.e., 86%) had disclosed their HIV status to their partners at the
baseline visit, and that many of their partners had been tested for HIV. This is a higher level of
partner HIV testing than reported in other locations [25, 29–31] and may be because many
PLHIV in our PwP program had been receiving HIV care and treatment services for several
years, and HIV services, including testing, are widely accessible free of charge in Thailand.
Unlike other PwP evaluations [32–34], we did not find an increase in contraceptive use among
sexually active PLHIV during follow-up. The high level of contraceptive use at baseline (i.e.,
94%) may have made additional gains challenging [8].
Prevention with positives among people living with HIV, Thailand
PLOS ONE | DOI:10.1371/journal.pone.0170558 February 3, 2017 10 / 14
This assessment of the implementation of a PwP program has several limitations. The
assessment was focused in hospitals where PwP interventions were implemented and we did
not have a control group. Data used in the analysis were collected in 2008–2009 and may not
reflect the current situation in Thailand [14, 31]. Our analysis was limited to data collected
from PLHIV evaluated at tertiary care facilities in Bangkok and a community hospital in
Chiang Rai, results from other settings may differ. We used participant self-reports of risk
behaviors that are vulnerable to social desirability bias and may result in under-reporting of
risk behaviors [35]. We did not perform a standardized set of laboratory tests to diagnosis STIs
among all participants; testing was based on clinical signs and symptoms. This may have led to
an underestimate of STI prevalence among PLHIV. Our analysis was limited to a highly
selected population of participants who successfully completed a baseline assessment and three
follow-up visits. This may have selected for participants more likely to adhere to clinical rec-
ommendations. In addition, most participants in this study were heterosexual and did not
inject drugs. The effect of this PwP package may differ among people who inject drugs and
MSM and additional research is clearly needed.
In summary, our analysis of PwP services at five hospitals in Thailand showed that the
implementation of a PwP program was associated with a decrease in risk behaviors that can
lead to HIV transmission. Based on these findings, the Thailand MOPH began to scale-up the
PwP model throughout the country in 2010–2011 [36] and the model has been integrated into
routine HIV care. The capacity to deliver HIV PwP services should be strengthened at hospi-
tals delivering HIV treatment and care services. Further studies are needed to assess the long-
term impact of PwP interventions on HIV incidence in the era of “test and treat regardless of
CD4 count” and the impact of PwP interventions on key populations including MSM, trans-
gender people, and people who inject drugs.
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